NCT00503022View on ClinicalTrials.gov

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2006

Conditions
Wet Age-Related Macular Degeneration
Interventions
DRUG

ACZ885

Trial Locations (8)

Unknown

Bern

Belfast, Northern Ireland

Bristol

Liverpool

London

Nottingham

Southampton

Wolverhampton

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY